Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 725 of 1294 entries
View as:

Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature

Phase: N/A Priority: Normal
NCT ID: NCT01778023 Org: User:
Start: 01/17/13 End: 12/17/14 Due: 12/17/15

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Phase: N/A Priority: Normal
NCT ID: NCT01562457 Org: User:
Start: 11/30/05 End: 04/30/06 Due: 04/30/07

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02754817 Org: User:
Start: 04/26/16 End: 10/20/16 Due: 10/20/17

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00676819 Org: User:
Start: 01/10/02 End: 07/19/02 Due: 07/19/03

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00523042 Org: User:
Start: 08/30/07 End: 02/28/08 Due: 02/28/09

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00676741 Org: User:
Start: 02/29/08 End: 05/31/10 Due: 05/31/11

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02938572 Org: User:
Start: 10/19/16 End: 07/04/17 Due: 07/04/18

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Phase: N/A Priority: Normal
NCT ID: NCT00697320 Org: User:
Start: 06/30/08 End: 12/31/10 Due: 12/31/11

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives

Phase: N/A Priority: Normal
NCT ID: NCT02241694 Org: User:
Start: 11/30/14 End: 07/31/15 Due: 07/31/16

Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02568280 Org: User:
Start: 10/06/15 End: 04/25/16 Due: 04/25/17

A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04698018 Org: User:
Start: 04/20/21 End: 04/25/23 Due: 04/25/24

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Phase: N/A Priority: Normal
NCT ID: NCT01228669 Org: User:
Start: 10/25/10 End: 09/10/12 Due: 09/10/13

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

Phase: N/A Priority: Normal
NCT ID: NCT00869908 Org: User:
Start: 11/30/08 End: 03/31/11 Due: 03/31/12

A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02501161 Org: User:
Start: 01/31/16 End: 10/03/18 Due: 10/03/19

DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy

Phase: N/A Priority: Normal
NCT ID: NCT05755360 Org: User:
Start: 02/21/23 End: 10/31/24 Due: 10/31/25

Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01497600 Org: User:
Start: 02/29/04 End: 08/31/04 Due: 08/31/05

Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

Phase: N/A Priority: Normal
NCT ID: NCT00313001 Org: User:
Start: 04/30/06 End: 07/31/07 Due: 07/31/08

Awareness, Care and Treatment in Obesity Management

Phase: N/A Priority: Normal
NCT ID: NCT03235102 Org: User:
Start: 08/03/17 End: 10/11/17 Due: 10/11/18

A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00964964 Org: User:
Start: 08/31/09 End: 09/30/09 Due: 09/30/10

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04109508 Org: User:
Start: 10/02/19 End: 01/27/21 Due: 01/27/22

Safety and Efficacy of Long-term Somatropin Treatment in Children

Phase: N/A Priority: Normal
NCT ID: NCT01543867 Org: User:
Start: 01/31/01 End: 12/31/11 Due: 12/31/12

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04601740 Org: User:
Start: 11/17/20 End: 11/01/22 Due: 11/01/23

Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00560924 Org: User:
Start: 03/21/03 End: 03/17/04 Due: 03/17/05

Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01563458 Org: User:
Start: 08/31/01 End: 08/31/03 Due: 08/31/04

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00670722 Org: User:
Start: 01/31/08 End: 12/31/09 Due: 12/31/10